Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota
Danfeng Chen, Duochen Jin, Shumin Huang, et al.
Cancer Letters (2019) Vol. 469, pp. 456-467
Closed Access | Times Cited: 352

Showing 1-25 of 352 citing articles:

Host–microbiota maladaptation in colorectal cancer
Alina Janney, Fiona Powrie, Elizabeth H. Mann
Nature (2020) Vol. 585, Iss. 7826, pp. 509-517
Closed Access | Times Cited: 316
Oscillospira - a candidate for the next-generation probiotics
Jingpeng Yang, Yanan Li, Zhiqiang Wen, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 294
Role of microbiota-derived short-chain fatty acids in cancer development and prevention
Rasoul Mirzaei, Azam Afaghi, Sajad Babakhani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111619-111619
Open Access | Times Cited: 284
Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease
Pooja S. Salvi, Robert A. Cowles
Cells (2021) Vol. 10, Iss. 7, pp. 1775-1775
Open Access | Times Cited: 276
Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease
Magdalena K. Stoeva, Jeewon Garcia-So, Nicholas J. Justice, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 261
Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 260
Butyrate producers, “The Sentinel of Gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics
Vineet Singh, GyuDae Lee, HyunWoo Son, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 241
Postbiotics: Current Trends in Food and Pharmaceutical Industry
Priyamvada Thorakkattu, Anandu Chandra Khanashyam, Kartik Shah, et al.
Foods (2022) Vol. 11, Iss. 19, pp. 3094-3094
Open Access | Times Cited: 172
The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases
Estefania Sánchez-Rodríguez, Alejandro Egea-Zorrilla, Julio Plaza‐Díaz, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 605-605
Open Access | Times Cited: 171
Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Huiqin Hou, Danfeng Chen, Kexin Zhang, et al.
Cancer Letters (2021) Vol. 526, pp. 225-235
Closed Access | Times Cited: 152
Cell primitive-based biomimetic functional materials for enhanced cancer therapy
Guo‐Feng Luo, Wei‐Hai Chen, Xuan Zeng, et al.
Chemical Society Reviews (2020) Vol. 50, Iss. 2, pp. 945-985
Closed Access | Times Cited: 144
Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
Teng Ma, Xin Shen, Xuan Shi, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 178-198
Open Access | Times Cited: 131
gutMGene: a comprehensive database for target genes of gut microbes and microbial metabolites
Liang Cheng, Changlu Qi, Haixiu Yang, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D795-D800
Open Access | Times Cited: 128
Wnt signaling pathway in cancer immunotherapy
Yang Zhou, Xu Jiang, Haichang Luo, et al.
Cancer Letters (2021) Vol. 525, pp. 84-96
Closed Access | Times Cited: 128
Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer
María Daniella Carretta, John Quiroga, Rodrigo López‐Muñoz, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 116
Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases
Baoyi Guan, Jinlin Tong, Haiping Hao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 5, pp. 2129-2149
Open Access | Times Cited: 110
Roseburia intestinalisgenerated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+T cells
Xing Kang, Changan Liu, Yanqiang Ding, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2112-2122
Open Access | Times Cited: 96
Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Ruize Qu, Yi Zhang, Yanpeng Ma, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 94
Interactive Relationships between Intestinal Flora and Bile Acids
Xiaohua Guo, Edozie Samuel Okpara, Wanting Hu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8343-8343
Open Access | Times Cited: 92
Faecalibacterium prausnitzii Attenuates CKD via Butyrate-Renal GPR43 Axis
Hong‐Bao Li, Menglu Xu, Xudong Xu, et al.
Circulation Research (2022) Vol. 131, Iss. 9
Open Access | Times Cited: 92
Progress of engineered bacteria for tumor therapy
Jin‐Xuan Fan, Mei‐Ting Niu, You‐Teng Qin, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114296-114296
Closed Access | Times Cited: 70
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 866-866
Open Access | Times Cited: 67
Colorectal cancer and gut microbiota studies in China
Zikai Wang, Wanyue Dan, Nana Zhang, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 51
The microbial landscape of colorectal cancer
Maxwell T. White, Cynthia L. Sears
Nature Reviews Microbiology (2023) Vol. 22, Iss. 4, pp. 240-254
Closed Access | Times Cited: 50
Next-generation probiotics: the upcoming biotherapeutics
Omnia Momtaz Al-Fakhrany, Engy Elekhnawy
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top